-1 Shiravandi, A, Yari, F, Tofigh, N et al. (2022) Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor. Biosensors 12(10):879.
-2 Busche, MA and Hyman, BT. (2020) Synergy between amyloid-β and tau in Alzheimer’s disease. Nature neuroscience 23(10):1183-1193.
-3 Albayram, O, Herbert, MK, Kondo, A et al. (2016) Function and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegeneration. Cell & Bioscience 6(1):1-6.
-4 Hu, C, Zuo, H and Li, Y. (2021) Effects of radiofrequency electromagnetic radiation on neurotransmitters in the brain. Frontiers in Public Health:1139.
-5 Touitou, Y and Selmaoui, B. (2022) The effects of extremely low-frequency magnetic fields on melatonin and cortisol, two marker rhythms of the circadian system. Dialogues in clinical neuroscience.
-6 Dasdag, O, Adalier, N and Dasdag, S. (2020) Electromagnetic radiation and Alzheimer’s disease. Biotechnology & Biotechnological Equipment 34(1):1087-1094.
-7 Wyszkowska, J and Pritchard, C. (2022) Open Questions on the Electromagnetic Field Contribution to the Risk of Neurodegenerative Diseases. International Journal of Environmental Research and Public Health 19(23):16150.
-8 Jalilian, H, Teshnizi, SH, Röösli, M and Neghab, M. (2018) Occupational exposure to extremely low frequency magnetic fields and risk of Alzheimer disease: a systematic review and meta-analysis. Neurotoxicology 69:242-252.
-9 Jooyana N., GB, Bigdelia B., Faraji-Danab R., ZamanicA., Entezamib M., Mortazavi S.M.J.,. (2019) Direct and indirect effects of exposure to 900 MHz GSM radiofrequency electromagnetic fields on CHO cell line: Evidence of bystander effect by nonionizing radiation. Environmental Research 174:176-187. doi:https://doi.org/10.1016/j.envres.2019.03.063.
-10 Agholme, L, Lindström, T, Kågedal, K, Marcusson, J and Hallbeck, M. (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. Journal of Alzheimer's disease 20(4):1069-1082.
-11 Nisbet, RM and Götz, J. (2018) Amyloid-β and Tau in Alzheimer’s disease: novel pathomechanisms and non-pharmacological treatment strategies. Journal of Alzheimer's Disease 64(s1):S517-S527.
-12 Davanipour, Z and Sobel, E. (2009) Long-term exposure to magnetic fields and the risks of Alzheimer's disease and breast cancer: Further biological research. Pathophysiology 16(2-3):149-156.
-13 D’Angelo, C, Costantini, E, Kamal, M and Reale, M. (2015) Experimental model for ELF-EMF exposure: Concern for human health. Saudi journal of biological sciences 22(1):75-84.
-14 Huss, A, Spoerri, A, Egger, M, Röösli, M and Study, SNC. (2009) Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population. American journal of epidemiology 169(2):167-175.
-15 García, AM, Sisternas, A and Hoyos, SP. (2008) Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. International journal of epidemiology 37(2):329-340.
-16 Dasdag, S, Akdag, MZ, Kizil, G, Kizil, M, Cakir, DU and Yokus, B. (2012) Effect of 900 MHz radio frequency radiation on beta amyloid protein, protein carbonyl, and malondialdehyde in the brain. Electromagnetic biology and medicine 31(1):67-74.
-17 Nakamura, K, Greenwood, A, Binder, L et al. (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 149(1):232-244.